Annual Interest Expense
$656.00 K
-$1.14 M-63.54%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual interest expense is currently $656.00 thousand, with the most recent change of -$1.14 million (-63.54%) on 31 December 2023. During the last 3 years, it has fallen by -$26.76 million (-97.61%). LGND annual interest expense is now -98.64% below its all-time high of $48.28 million, reached on 31 December 2018.LGND Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$741.00 K
-$527.00 K-41.56%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly interest expense is currently $741.00 thousand, with the most recent change of -$527.00 thousand (-41.56%) on 30 September 2024. Over the past year, it has increased by +$740.00 thousand (+74000.00%). LGND quarterly interest expense is now -96.32% below its all-time high of $20.14 million, reached on 31 December 2018.LGND Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$2.28 M
+$740.00 K+48.02%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated TTM interest expense is currently $2.28 million, with the most recent change of +$740.00 thousand (+48.02%) on 30 September 2024. Over the past year, it has increased by +$1.52 million (+198.17%). LGND TTM interest expense is now -95.75% below its all-time high of $53.70 million, reached on 31 March 2019.LGND TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.5% | +10000.0% | +198.2% |
| 3 y3 years | -97.6% | -83.3% | -89.4% |
| 5 y5 years | -98.6% | -91.8% | -95.2% |
LGND Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -97.6% | at low | -83.4% | >+9999.0% | -89.4% | +309.5% |
| 5 y | 5 years | -98.6% | at low | -91.8% | >+9999.0% | -95.2% | +309.5% |
| alltime | all time | -98.6% | +1031.0% | -96.3% | >+9999.0% | -95.8% | +4286.5% |
Ligand Pharmaceuticals Incorporated Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $741.00 K(-41.6%) | $2.28 M(+48.0%) |
| June 2024 | - | $1.27 M(+799.3%) | $1.54 M(+176.7%) |
| Mar 2024 | - | $141.00 K(+7.6%) | $557.00 K(-15.1%) |
| Dec 2023 | $656.00 K(-63.5%) | $131.00 K(>+9900.0%) | $656.00 K(-14.2%) |
| Sept 2023 | - | $1000.00(-99.6%) | $765.00 K(-30.2%) |
| June 2023 | - | $284.00 K(+18.3%) | $1.10 M(-12.3%) |
| Mar 2023 | - | $240.00 K(0.0%) | $1.25 M(-30.5%) |
| Dec 2022 | $1.80 M(-90.8%) | $240.00 K(-27.7%) | $1.80 M(-70.1%) |
| Sept 2022 | - | $332.00 K(-24.2%) | $6.02 M(-40.5%) |
| June 2022 | - | $438.00 K(-44.5%) | $10.13 M(-30.5%) |
| Mar 2022 | - | $789.00 K(-82.3%) | $14.58 M(-25.7%) |
| Dec 2021 | $19.62 M(-28.4%) | $4.46 M(+0.6%) | $19.62 M(-8.9%) |
| Sept 2021 | - | $4.44 M(-9.1%) | $21.54 M(-7.8%) |
| June 2021 | - | $4.88 M(-16.3%) | $23.37 M(-5.4%) |
| Mar 2021 | - | $5.83 M(-8.7%) | $24.70 M(-9.9%) |
| Dec 2020 | $27.41 M(-23.3%) | $6.38 M(+1.9%) | $27.41 M(-8.2%) |
| Sept 2020 | - | $6.27 M(+0.9%) | $29.86 M(-8.4%) |
| June 2020 | - | $6.21 M(-27.3%) | $32.59 M(-7.9%) |
| Mar 2020 | - | $8.55 M(-3.2%) | $35.39 M(-1.0%) |
| Dec 2019 | $35.74 M | $8.83 M(-1.8%) | $35.74 M(-24.0%) |
| Sept 2019 | - | $8.99 M(-0.2%) | $47.05 M(-4.5%) |
| June 2019 | - | $9.01 M(+1.2%) | $49.26 M(-8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $8.91 M(-55.8%) | $53.70 M(+11.2%) |
| Dec 2018 | $48.28 M(+258.7%) | $20.14 M(+79.8%) | $48.28 M(+52.9%) |
| Sept 2018 | - | $11.20 M(-16.8%) | $31.57 M(+32.9%) |
| June 2018 | - | $13.45 M(+286.6%) | $23.75 M(+74.1%) |
| Mar 2018 | - | $3.48 M(+1.4%) | $13.64 M(+34.3%) |
| Dec 2017 | $13.46 M(+4.8%) | $3.43 M(+1.4%) | $10.16 M(+51.0%) |
| Sept 2017 | - | $3.39 M(+1.3%) | $6.73 M(+101.3%) |
| June 2017 | - | $3.34 M(+395.7%) | $3.34 M(+197.2%) |
| Dec 2016 | $12.84 M(>+9900.0%) | - | - |
| June 2011 | - | $674.00 K(+59.3%) | $1.12 M(+142.8%) |
| Mar 2011 | - | $423.00 K(+2126.3%) | $463.00 K(+698.3%) |
| Dec 2010 | $58.00 K(-78.5%) | $19.00 K(+137.5%) | $58.00 K(+11.5%) |
| Sept 2010 | - | $8000.00(-38.5%) | $52.00 K(-20.0%) |
| June 2010 | - | $13.00 K(-27.8%) | $65.00 K(-30.9%) |
| Mar 2010 | - | $18.00 K(+38.5%) | $94.00 K(-65.2%) |
| Dec 2009 | $270.00 K(+33.7%) | $13.00 K(-38.1%) | $270.00 K(+5.1%) |
| Sept 2009 | - | $21.00 K(-50.0%) | $257.00 K(+8.9%) |
| June 2009 | - | $42.00 K(-78.4%) | $236.00 K(+21.6%) |
| Mar 2009 | - | $194.00 K(+273.1%) | $194.00 K(+273.1%) |
| Dec 2008 | $202.00 K(-72.5%) | - | - |
| Mar 2008 | - | $52.00 K | $52.00 K |
| Dec 2007 | $735.00 K | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual interest expense?
- What is the all time high annual interest expense for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual interest expense year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly interest expense?
- What is the all time high quarterly interest expense for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM interest expense?
- What is the all time high TTM interest expense for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM interest expense year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual interest expense?
The current annual interest expense of LGND is $656.00 K
What is the all time high annual interest expense for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual interest expense is $48.28 M
What is Ligand Pharmaceuticals Incorporated annual interest expense year-on-year change?
Over the past year, LGND annual interest expense has changed by -$1.14 M (-63.54%)
What is Ligand Pharmaceuticals Incorporated quarterly interest expense?
The current quarterly interest expense of LGND is $741.00 K
What is the all time high quarterly interest expense for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly interest expense is $20.14 M
What is Ligand Pharmaceuticals Incorporated quarterly interest expense year-on-year change?
Over the past year, LGND quarterly interest expense has changed by +$740.00 K (+74000.00%)
What is Ligand Pharmaceuticals Incorporated TTM interest expense?
The current TTM interest expense of LGND is $2.28 M
What is the all time high TTM interest expense for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM interest expense is $53.70 M
What is Ligand Pharmaceuticals Incorporated TTM interest expense year-on-year change?
Over the past year, LGND TTM interest expense has changed by +$1.52 M (+198.17%)